Telos Capital Management’s Gilead Sciences GILD Stock Holding History

Telos Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,436	Closed	-$200K	–	203
2026 Q1	$200K	Buy	+1,436	New	+$201K	0.02%	190
2016 Q4	–	Sell	-14,775	Closed	-$1.17M	–	143
2016 Q3	$1.17M	Sell	14,775 -221	-1%	-$18K	0.54%	71
2016 Q2	$1.25M	Sell	14,996 -13	-0.1%	-$1.15K	0.61%	70
2016 Q1	$1.38M	Buy	15,009 +1,856	+14%	+$167K	0.72%	59
2015 Q4	$1.33M	Buy	13,153 +2,156	+20%	+$224K	0.72%	59
2015 Q3	$1.08M	Buy	10,997 +8,781	+396%	+$975K	0.66%	59
2015 Q2	$259K	Buy	+2,216	New	+$242K	0.14%	130

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Telos Capital Management's GILD Position: Q2 2026 in Review

Telos Capital Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,436 shares — an estimated $200K sold.

Telos Capital Management first reported a position in GILD in Q2 2015 and held it in 7 quarters. The position peaked at $1.38M in Q1 2016. 721 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Telos Capital Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
Telos Capital Management sold 1,436 Gilead Sciences shares in Q2 2026, an estimated $200K.
Telos Capital Management first reported a position in Gilead Sciences in Q2 2015 and held it in 7 quarters.
Telos Capital Management's Gilead Sciences position peaked at $1.38M in Q1 2016.
721 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Telos Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.